Propofol in terminal care

Journal of Pain and Symptom Management
S MercadanteC Ripamonti

Abstract

In advanced cancer patients close to death, delirium, multifocal myoclonus, and restlessness may occur. Multi-organ failure and related metabolic changes are mostly responsible for these symptoms. A pharmacologic approach to manage the delirium is necessary in the majority of cases. Benzodiazepines, neuroleptics, and barbiturates are the most common drugs used. In the case reported, propofol administered at very low doses provided good control of neuropsychiatric symptoms. After a loading dose of 20 mg, an infusion of 50-70 mg per hr was started. The patient died peacefully after 8 hr of propofol infusion, without requiring opioids. Propofol seems to be a promising drug in treating the terminal agitated state that can be associated with the dying process.

References

Jan 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·S Raftery, E Sherry
May 1, 1992·Journal of Clinical Anesthesia·E TaylorP F White
Oct 25, 1986·British Medical Journal·A FoyP Mearrick
Dec 13, 1986·British Medical Journal·C E Daman Willems, M J Dillon
Feb 14, 1987·British Medical Journal·R M GroundsM Morgan
Aug 1, 1983·The American Journal of Psychiatry·M J MassieE Glass
Dec 1, 1994·Anesthesia and Analgesia·B L AppaduD G Lambert
Oct 1, 1993·Anesthesia and Analgesia·M B Sosis, B Braverman
Oct 1, 1993·Anaesthesia·A C QuinnR M Grounds

❮ Previous
Next ❯

Citations

Apr 9, 2002·Current Oncology Reports·John D Cowan, Teresa W Palmer
Apr 20, 2001·Journal of Pain and Symptom Management·T MoritaS Chihara
Mar 13, 2002·Journal of Pain and Symptom Management·Christine ChengJose Pereira
Aug 10, 2000·Anesthesiology Clinics of North America·P J Hoehner
Apr 6, 2006·Palliative & Supportive Care·Daniele StagnoWilliam Breitbart
Sep 7, 2006·Nature Clinical Practice. Oncology·Nathan I Cherny
Apr 30, 2005·Journal of Palliative Medicine·J L Shuster
Feb 15, 2007·Journal of Palliative Medicine·Alexander de Graeff, Mervyn Dean
Oct 16, 2009·Journal of Palliative Medicine·Kerry McWilliamsEsther T Waterhouse
Sep 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N I Cherny, UNKNOWN ESMO Guidelines Working Group
Sep 8, 2010·Journal of Pain and Symptom Management·Staffan LundströmAndrew Wilcock
Mar 14, 2017·Journal of Pain & Palliative Care Pharmacotherapy·John Bodnar
Oct 28, 2009·Palliative Medicine·Nathan I ChernyUNKNOWN Board of the European Association for Palliative Care
Dec 23, 2006·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Mary C HookeBruce Bostrom
May 1, 1997·Clinical Pediatrics·J D Tobias
Jun 14, 2008·The American Journal of Hospice & Palliative Care·Christopher M Herndon, Ethan Zimmerman
Oct 15, 2019·Journal of Pain & Palliative Care Pharmacotherapy·John Bodnar
Sep 7, 2019·BMJ Supportive & Palliative Care·Merlina SulistioNatasha G Michael
May 1, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Edith Monreal-CarrilloEmma Verástegui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of Pain and Symptom Management
J Moyle
Journal of Pain and Symptom Management
Staffan LundströmCarl Johan Fürst
Journal of Pain and Symptom Management
Christine ChengJose Pereira
Journal of Pain and Symptom Management
R L FainsingerE Bruera
© 2021 Meta ULC. All rights reserved